NEWS

News Articles

Aruna Bio Awarded $4.5 Million SBIR Phase II Grant to Support Development of Neural Exosome AB126

October 10, 2019

Grant will support progressing AB126 to an Investigational New Drug (IND) application for acute ischemic stroke   Athens, GA and Research Triangle Park, NC — October 10, 2019 — Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the company has been awarded a Small Business…

Read More

Boehringer Ingelheim Completes Plant Expansion After $76 Million Georgia Investment

October 9, 2019

DULUTH, Ga., Oct. 9, 2019 /PRNewswire/ — Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76 millioninvestment in its site in Athens, Ga. The investment doubled the company’s capacity to produce vaccines for pets in the United Statesand around the world. “Today’s announcement is representative of the growth…

Read More

Biotechnology Innovation Organization Announces 2021 Leadership Transition

October 8, 2019

The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new leader to represent the industry globally and to defend innovation from domestic political attacks. Biotechnology Innovation Organization Announces 2021 Leadership Transition…

Read More

Historic NIH research grants to UGA, Emory could exceed $200 million

October 2, 2019

Funding validates GRA’s Eminent Scholar model This week’s news that the National Institutes of Health (NIH) has awarded two Georgia universities major grants to advance work toward a universal flu vaccine is more than a testament to their sophisticated research programs. It also reflects how the Georgia Research Alliance’s efforts to recruit world-class scientists to Georgia…

Read More

NIH awards up to $130M for flu vaccine development to University of Georgia

September 30, 2019

UGA to lead effort aimed at protecting vulnerable populations The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to…

Read More

Georgia Bio to Showcase State’s Leadership and Patients’ Perspectives in Bioscience Innovation at 2019 Innovation Summit

September 27, 2019

The Georgia Bio Innovation Summit is the southeast’s largest life science conference, showcasing Georgia’s leadership in innovation to improve the health and well-being of people, animals and the environment. This year’s Summit will bring together hundreds of CEOs, senior executives, scientists and public policy officials from Georgia and across the nation on October 8 at the Cobb Galleria in Atlanta.

Read More